WallStreetZenWallStreetZen

NASDAQ: FDMT
4d Molecular Therapeutics Revenue

OverviewForecastEarningsRevenue
DividendOwnership
4d Molecular Therapeutics revenue was $37.00k for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. Quarterly revenue for the quarter (Q4 2024) ending on Dec 31, 2024 was $1.0k, down 66.7% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, FDMT annual revenue was $37.0k, with -99.8% growth year-over-year.

FDMT past revenue growth

How has FDMT's revenue growth performed historically?

Company
-99.82%
Industry
443.32%
Market
20.2%
FDMT's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
FDMT's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
FDMT's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

FDMT revenue history

Current Revenue
$37.0k
Current Earnings
-$160.9M
Current Profit Margin
-434,778.4%

Be the first to know when FDMT announces revenue.

FDMT Revenue History By Year

FDMT Yearly RevenueFDMT RevenueFDMT ChangeFDMT Revenue Growth
2024-12-31$37.00k-$20.69M-99.82%
2023-12-31$20.72M$17.59M+562.29%
2022-12-31$3.13M-$14.91M-82.65%
2021-12-31$18.04M$4.43M+32.52%
2020-12-31$13.61M$6.63M+94.85%
2019-12-31$6.99M-$7.14M-50.56%
2018-12-31$14.13MN/AN/A

1 of 1

4d Molecular Therapeutics Revenue FAQ

What was FDMT's revenue last quarter?

On Invalid Date, 4d Molecular Therapeutics (NASDAQ: FDMT) reported Q4 2024 revenue of $1.00 thousand up 105.26% year over year. In the same quarter last year, 4d Molecular Therapeutics's revenue was -$19.00 thousand.

What was 4d Molecular Therapeutics's revenue in 2024?

4d Molecular Therapeutics's annual revenue for the twelve months ending Dec 31, 2024 was $37.00 thousand, a 99.82% decrease year over year.

How much does 4d Molecular Therapeutics make in a day?

Based on 4d Molecular Therapeutics annual revenue for the past five years, FDMT makes an average of $30,432.33 per day.

What was 4d Molecular Therapeutics's annual revenue growth in the past year?

As of Q2 2025, 4d Molecular Therapeutics's revenue has grown -99.82% year over year. This is 543.14 percentage points lower than the US Biotechnology industry revenue growth rate of 443.32%. 4d Molecular Therapeutics's revenue in the past year totaled $37.00 thousand.

How much does 4d Molecular Therapeutics make in a year?

4d Molecular Therapeutics's revenue by year for the past five years is:
  • 4d Molecular Therapeutics's revenue for the twelve months ending Dec 31, 2024 was $37.00 thousand, a 99.82% decrease year over year.
  • 4d Molecular Therapeutics's annual revenue for Dec 31, 2023 was $20.72 million, a 562.29% increase from 2022.
  • 4d Molecular Therapeutics's annual revenue for 2022 was $3.13 million, a 82.65% decrease from 2021.
  • 4d Molecular Therapeutics's annual revenue for 2021 was $18.04 million, a 32.52% increase from 2020.
  • 4d Molecular Therapeutics's annual revenue for 2020 was $13.61 million, a 94.85% increase from 2019.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.